← Open Payments lookup

EMILY MOORE: Open Payments

NPI 1114607553 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,114 in 94 payments from 18 companies in 2025. Trend: 2023 $78 · 2024 $1,430 · 2025 $2,114

Food & beverage: $2,030Education: $84
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.19$546
ABBVIE INC.29$524
Madrigal Pharmaceuticals8$224
Janssen Biotech, Inc.8$196
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$106
Ipsen Biopharmaceuticals, Inc4$74
CVRx, Inc.3$55
Ardelyx, Inc.3$54
Regeneron Healthcare Solutions, Inc.3$53
Lilly USA, LLC2$45

Products named: ENTYVIO, REZDIFFRA, RINVOQ, GATTEX, TREMFYA, LINZESS, CREON, XIFAXAN.

Industry payments across TX — which companies pay providers there.